Hsbc Holdings PLC Galapagos Nv Transaction History

Hsbc Holdings PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$185.52 - $231.25 $299,800 - $373,700	-1,616 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $88,088 - $168,802	616 Added 61.6%	1,616 $308,000
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $146,120 - $215,820	1,000 New	1,000 $207,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.